FLXN stock forecast
Our latest prediction for Flexion Therapeutics, Inc.'s stock price was made on the May 26, 2020 when the stock price was at 9.69$.
In the short term (2weeks), FLXN's stock price should outperform the market by 1.22%. During that period the price should oscillate between -9.81% and +11.13%.
In the medium term (3months), FLXN's stock price should underperform the market by -8.67%. During that period the price should oscillate between -38.96% and +24.11%.
Get email alertsCreate a solid portfolio with FLXN
About Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.
At the moment the company generates 83M USD in revenues.
On its last earning announcement, the company reported a loss of -3.79$ per share.
The book value per share is 4.91$
Three months stock forecastMay 26, 2020
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83M | 87.30% | -130M | -157.50% | -145M | -3.79 | - | - | 38M | 4.91 | -139M | -6M | -145M |